11-105611067-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_000829.4(GRIA4):c.70C>T(p.Pro24Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000031 in 1,612,880 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 29)
Exomes 𝑓: 0.0000021 ( 0 hom. )
Consequence
GRIA4
NM_000829.4 missense
NM_000829.4 missense
Scores
3
6
10
Clinical Significance
Conservation
PhyloP100: 5.47
Genes affected
GRIA4 (HGNC:4574): (glutamate ionotropic receptor AMPA type subunit 4) Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. These receptors are heteromeric protein complexes composed of multiple subunits, arranged to form ligand-gated ion channels. The classification of glutamate receptors is based on their activation by different pharmacologic agonists. The subunit encoded by this gene belongs to a family of AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate)-sensitive glutamate receptors, and is subject to RNA editing (AGA->GGA; R->G). Alternative splicing of this gene results in transcript variants encoding different isoforms, which may vary in their signal transduction properties. Some haplotypes of this gene show a positive association with schizophrenia. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151950Hom.: 0 Cov.: 29
GnomAD3 genomes
AF:
AC:
2
AN:
151950
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1460930Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 726858
GnomAD4 exome
AF:
AC:
3
AN:
1460930
Hom.:
Cov.:
30
AF XY:
AC XY:
2
AN XY:
726858
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151950Hom.: 0 Cov.: 29 AF XY: 0.0000270 AC XY: 2AN XY: 74188
GnomAD4 genome
AF:
AC:
2
AN:
151950
Hom.:
Cov.:
29
AF XY:
AC XY:
2
AN XY:
74188
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Neurodevelopmental disorder with or without seizures and gait abnormalities Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | May 23, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;.;T;.;.;.;.;T;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;.;.;D;D;D;D;D;D;.;.
M_CAP
Benign
T
MetaRNN
Uncertain
D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;.;L;.;.;.;L;.;.;L
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;D;D;N;N;D;D;D;D;N;N
REVEL
Benign
Sift
Benign
T;T;T;T;T;T;T;T;T;T;T
Sift4G
Benign
T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.88, 0.99
.;.;.;P;D;.;.;.;.;D;P
Vest4
0.45, 0.45, 0.56, 0.41, 0.49, 0.48
MutPred
Gain of catalytic residue at P24 (P = 0.0237);Gain of catalytic residue at P24 (P = 0.0237);Gain of catalytic residue at P24 (P = 0.0237);Gain of catalytic residue at P24 (P = 0.0237);Gain of catalytic residue at P24 (P = 0.0237);Gain of catalytic residue at P24 (P = 0.0237);Gain of catalytic residue at P24 (P = 0.0237);Gain of catalytic residue at P24 (P = 0.0237);Gain of catalytic residue at P24 (P = 0.0237);Gain of catalytic residue at P24 (P = 0.0237);Gain of catalytic residue at P24 (P = 0.0237);
MVP
MPC
0.29
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at